Clinical Trial Update: A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pitolisant (BF2.649) for alcohol use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Pitolisant (BF2.649) (pitolisant)

Snippet

Sponsor: Bioprojet | Conditions: Alcohol Abuse, Nervous System | Phase 2 | Status: WITHDRAWN